Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is one of the stocks under $1 that will explode. Sangamo Therapeutics, Inc.’s ...

Detailed price information for Sangamo Therapeutics (SGMO-Q) from The Globe and Mail including charting and trades.

STAAR study demonstrated positive mean annualized estimated glomerular filtration rate (eGFR) slope at 52-weeks across all dosed patients in the study, which U.S. Food and Drug Administration (FDA) ...

Tango Therapeutics ( ($TNGX) ) has shared an announcement. On January 2, 2026, Tango Therapeutics, Inc. expanded its Board of Directors from seven ...

Seasoned biotech executive brings over 25 years of leadership experience across financial strategy and operations, investor relations and business development DURHAM, N.C., Jan. 06, 2026 (GLOBE ...

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the ...

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic ...

Therapies market, valued at USD 16.7 million in 2024, is expected to register robust revenue CAGR of 44.6%.Request free copy of this report: 13, 2026- The growing incidence of autoimmune disorders ...

Detailed price information for Sangamo Therapeutics (SGMO-Q) from The Globe and Mail including charting and trades.

BioMarin BMRN0.75%increase; green up pointing triangle Pharmaceutical has struck a deal to buy fellow biotech Amicus Therapeutics FOLD-0.07%decrease; red down pointing triangle for about $4.8 billion ...

Here is The State Journal-Register's Small School All-Area football team for 2025, listed in alphabetical order by school. See the Small School Player of the Year: Williamsville running back carries ...